Janus kinase (JAK) inhibitors are a group of medications that can treat various types of arthritis, including rheumatoid arthritis (RA), cancer, dermatological conditions like atopic dermatitis and ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

The researchers found nearly half (47%) of the posts focused on efficacy, while 16% discussed adverse effects such as acne, ...

An investigational oral Janus kinase (JAK) inhibitor failed to meet most primary endpoints in a phase III trial of patients with moderate to severe Crohn's disease, but the failures might have been ...

The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) inhibitors across the seven major pharmaceutical markets (7MM; USA, France, Germany ...

PhD Defense: Effectiveness and safety of dupilumab and JAK-inhibitors in daily practice; Optimizing Treatment for Atopic Dermatitis ...

The heat map illustrates the risk of cardiotoxic adverse events associated with various tyrosine kinase inhibitors (TKIs). The drugs are categorized by receptor type (EGFR, HER2, VEGFR, FGFR, BCR-ABL, ...